148 related articles for article (PubMed ID: 2527626)
21. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
[TBL] [Abstract][Full Text] [Related]
23. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
[TBL] [Abstract][Full Text] [Related]
24. The role of integrase/recombinase xerD and monofunctional biosynthesis peptidoglycan transglycosylase genes in the pathogenicity of Brucella abortus infection in vitro and in vivo.
Canavessi AM; Harms J; de Leon Gatti N; Splitter GA
Microb Pathog; 2004 Nov; 37(5):241-51. PubMed ID: 15519045
[TBL] [Abstract][Full Text] [Related]
25. [Brucella isolates in France: evaluation of 10 years of typing].
Verger JM; Duée JP; Grayon M
Ann Microbiol (Paris); 1982; 133(3):433-47. PubMed ID: 6819798
[TBL] [Abstract][Full Text] [Related]
26. BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis.
Leakey AK; Ulett GC; Hirst RG
Microb Pathog; 1998 May; 24(5):269-75. PubMed ID: 9600859
[TBL] [Abstract][Full Text] [Related]
27. The new species Brucella microti replicates in macrophages and causes death in murine models of infection.
Jiménez de Bagüés MP; Ouahrani-Bettache S; Quintana JF; Mitjana O; Hanna N; Bessoles S; Sanchez F; Scholz HC; Lafont V; Köhler S; Occhialini A
J Infect Dis; 2010 Jul; 202(1):3-10. PubMed ID: 20497040
[TBL] [Abstract][Full Text] [Related]
28. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
[TBL] [Abstract][Full Text] [Related]
29. Proteomic analyses of the time course responses of mice infected with Brucella abortus 544 reveal immunogenic antigens.
Lee JJ; Simborio HL; Reyes AW; Kim DG; Hop HT; Min W; Her M; Jung SC; Yoo HS; Kim S
FEMS Microbiol Lett; 2014 Aug; 357(2):164-74. PubMed ID: 24975114
[TBL] [Abstract][Full Text] [Related]
30. [A study on the role of immunosuppression in the pathogenesis of brucellosis].
Zhang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Jun; 14(3):168-72. PubMed ID: 1394733
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection.
Atkins HS; Spencer S; Brew SD; Jenner DC; Sefton AM; MacMillan AP; Brooks TJ; Simpson AJ
Int J Antimicrob Agents; 2010 Jul; 36(1):66-8. PubMed ID: 20022474
[TBL] [Abstract][Full Text] [Related]
32. Cutting Edge: Brucella abortus exploits a cellular prion protein on intestinal M cells as an invasive receptor.
Nakato G; Hase K; Suzuki M; Kimura M; Ato M; Hanazato M; Tobiume M; Horiuchi M; Atarashi R; Nishida N; Watarai M; Imaoka K; Ohno H
J Immunol; 2012 Aug; 189(4):1540-4. PubMed ID: 22772447
[TBL] [Abstract][Full Text] [Related]
33. Modelling the immunopathophysiology of Brucella melitensis and its lipopolysaccharide in mice infected via oral route of exposure.
Osman AY; Kadir AA; Jesse FF; Saharee AA
Microb Pathog; 2019 Nov; 136():103669. PubMed ID: 31445124
[TBL] [Abstract][Full Text] [Related]
34. [The cell wall fractions of Brucella are specific mitogens. Implications in the genesis of the primary immune response].
Renoux M; Renoux G; Néhémie C
C R Seances Soc Biol Fil; 1977; 171(1):248-52. PubMed ID: 143325
[TBL] [Abstract][Full Text] [Related]
35. Carboxyl-terminal protease regulates Brucella suis morphology in culture and persistence in macrophages and mice.
Bandara AB; Sriranganathan N; Schurig GG; Boyle SM
J Bacteriol; 2005 Aug; 187(16):5767-75. PubMed ID: 16077124
[TBL] [Abstract][Full Text] [Related]
36. The virB operon is essential for lethality of Brucella microti in the Balb/c murine model of infection.
Hanna N; Jiménez de Bagüés MP; Ouahrani-Bettache S; El Yakhlifi Z; Köhler S; Occhialini A
J Infect Dis; 2011 Apr; 203(8):1129-35. PubMed ID: 21451001
[TBL] [Abstract][Full Text] [Related]
37. Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors.
Kutlu M; Ergin Ç; Şen-Türk N; Sayin-Kutlu S; Zorbozan O; Akalın Ş; Şahin B; Çobankara V; Demirkan N
J Infect Dev Ctries; 2015 Feb; 9(2):141-8. PubMed ID: 25699488
[TBL] [Abstract][Full Text] [Related]
38. Immune response and differentially expressed proteins in the lung tissue of BALB/c mice challenged by aerosolized Brucella melitensis 5.
Fu Y; Wang Z; Lu B; Zhao S; Zhang Y; Zhao Z; Zhang C; Li J; Zhou B; Guo Z; Qian J; Liu L
J Int Med Res; 2018 Nov; 46(11):4740-4752. PubMed ID: 30282518
[TBL] [Abstract][Full Text] [Related]
39. Brucella pinnipedialis hooded seal (Cystophora cristata) strain in the mouse model with concurrent exposure to PCB 153.
Nymo IH; das Neves CG; Tryland M; Bårdsen BJ; Santos RL; Turchetti AP; Janczak AM; Djønne B; Lie E; Berg V; Godfroid J
Comp Immunol Microbiol Infect Dis; 2014 May; 37(3):195-204. PubMed ID: 24534631
[TBL] [Abstract][Full Text] [Related]
40. Comparative experimental study of Brucella melitensis and its lipopolysaccharide in mouse model infected via subcutaneous route of exposure.
Osman AY; Saharee AA; Jesse FF; Kadir AA
Microb Pathog; 2018 Mar; 116():318-327. PubMed ID: 29412161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
